AEterna Zentaris Inc (AEZS)
1.97
+0.02
(+0.77%)
USD |
NASDAQ |
Apr 23, 16:00
1.97
0.00 (0.00%)
After-Hours: 20:00
AEterna Zentaris Price to Book Value: 0.5257 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 23, 2024 | 0.5257 |
April 22, 2024 | 0.5217 |
April 19, 2024 | 0.5204 |
April 18, 2024 | 0.5222 |
April 17, 2024 | 0.5284 |
April 16, 2024 | 0.5204 |
April 15, 2024 | 0.5231 |
April 12, 2024 | 0.5271 |
April 11, 2024 | 0.5524 |
April 10, 2024 | 0.5457 |
April 09, 2024 | 0.5551 |
April 08, 2024 | 0.5497 |
April 05, 2024 | 0.5391 |
April 04, 2024 | 0.5551 |
April 03, 2024 | 0.5604 |
April 02, 2024 | 0.5636 |
April 01, 2024 | 0.5578 |
March 28, 2024 | 0.5844 |
March 27, 2024 | 0.5551 |
March 26, 2024 | 0.5337 |
March 25, 2024 | 0.5311 |
March 22, 2024 | 0.5524 |
March 21, 2024 | 0.5257 |
March 20, 2024 | 0.5524 |
March 19, 2024 | 0.5631 |
Date | Value |
---|---|
March 18, 2024 | 0.5604 |
March 15, 2024 | 0.5791 |
March 14, 2024 | 0.5337 |
March 13, 2024 | 0.5457 |
March 12, 2024 | 0.5444 |
March 11, 2024 | 0.5017 |
March 08, 2024 | 0.507 |
March 07, 2024 | 0.4937 |
March 06, 2024 | 0.5044 |
March 05, 2024 | 0.507 |
March 04, 2024 | 0.507 |
March 01, 2024 | 0.507 |
February 29, 2024 | 0.5097 |
February 28, 2024 | 0.499 |
February 27, 2024 | 0.5097 |
February 26, 2024 | 0.5204 |
February 23, 2024 | 0.5044 |
February 22, 2024 | 0.4628 |
February 21, 2024 | 0.475 |
February 20, 2024 | 0.4681 |
February 16, 2024 | 0.4867 |
February 15, 2024 | 0.4963 |
February 14, 2024 | 0.4756 |
February 13, 2024 | 0.4939 |
February 12, 2024 | 0.4804 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2624
Minimum
Nov 02 2023
37.03
Maximum
Aug 10 2020
3.580
Average
0.7536
Median
Jan 27 2022
Price to Book Value Benchmarks
Acasti Pharma Inc | 0.4185 |
Aurinia Pharmaceuticals Inc | 1.946 |
Edesa Biotech Inc | 2.423 |
Lexaria Bioscience Corp | 4.426 |
Xenon Pharmaceuticals Inc | 3.340 |
Price to Book Value Related Metrics
PS Ratio | 2.127 |
Price | 1.97 |
Earnings Yield | -173.1% |
Market Cap | 9.566M |